vs
亚什兰（ASH）与Guardian Pharmacy Services, Inc.（GRDN）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Guardian Pharmacy Services, Inc.的1.1倍（$386.0M vs $336.6M），Guardian Pharmacy Services, Inc.净利率更高（4.0% vs -3.1%，领先7.1%），Guardian Pharmacy Services, Inc.同比增速更快（2.2% vs -4.7%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
CVS药房是美国零售企业，为CVS健康旗下子公司，总部位于罗德岛州文索基特，前身为Consumer Value Stores，1963年在马萨诸塞州洛厄尔成立，是美国知名的零售药房服务提供商，在药品零售、健康服务领域拥有广泛的业务布局。
ASH vs GRDN — 直观对比
营收规模更大
ASH
是对方的1.1倍
$336.6M
营收增速更快
GRDN
高出6.9%
-4.7%
净利率更高
GRDN
高出7.1%
-3.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $336.6M |
| 净利润 | $-12.0M | $13.5M |
| 毛利率 | 27.2% | 22.7% |
| 营业利润率 | -1.6% | 5.3% |
| 净利率 | -3.1% | 4.0% |
| 营收同比 | -4.7% | 2.2% |
| 净利润同比 | 92.7% | 46.1% |
| 每股收益（稀释后） | $-0.26 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHGRDN
| Q1 26 | — | $336.6M | ||
| Q4 25 | $386.0M | $397.6M | ||
| Q3 25 | $477.0M | $377.4M | ||
| Q2 25 | $463.0M | $344.3M | ||
| Q1 25 | $479.0M | $329.3M | ||
| Q4 24 | $405.0M | — | ||
| Q3 24 | $521.0M | $314.4M | ||
| Q2 24 | $544.0M | — |
净利润ASHGRDN
| Q1 26 | — | $13.5M | ||
| Q4 25 | $-12.0M | $20.9M | ||
| Q3 25 | $31.0M | $9.8M | ||
| Q2 25 | $-742.0M | $9.0M | ||
| Q1 25 | $31.0M | $9.4M | ||
| Q4 24 | $-165.0M | — | ||
| Q3 24 | $17.0M | $-122.0M | ||
| Q2 24 | $6.0M | — |
毛利率ASHGRDN
| Q1 26 | — | 22.7% | ||
| Q4 25 | 27.2% | 21.5% | ||
| Q3 25 | 33.3% | 19.8% | ||
| Q2 25 | 28.5% | 19.8% | ||
| Q1 25 | 30.7% | 19.5% | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | 19.4% | ||
| Q2 24 | 34.2% | — |
营业利润率ASHGRDN
| Q1 26 | — | 5.3% | ||
| Q4 25 | -1.6% | 7.7% | ||
| Q3 25 | 12.8% | 4.3% | ||
| Q2 25 | -152.9% | 3.7% | ||
| Q1 25 | 10.6% | 3.9% | ||
| Q4 24 | -44.2% | — | ||
| Q3 24 | 6.1% | -33.3% | ||
| Q2 24 | -11.2% | — |
净利率ASHGRDN
| Q1 26 | — | 4.0% | ||
| Q4 25 | -3.1% | 5.3% | ||
| Q3 25 | 6.5% | 2.6% | ||
| Q2 25 | -160.3% | 2.6% | ||
| Q1 25 | 6.5% | 2.9% | ||
| Q4 24 | -40.7% | — | ||
| Q3 24 | 3.3% | -38.8% | ||
| Q2 24 | 1.1% | — |
每股收益（稀释后）ASHGRDN
| Q1 26 | — | $0.21 | ||
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $0.83 | — | ||
| Q2 25 | $-16.21 | — | ||
| Q1 25 | $0.65 | — | ||
| Q4 24 | $-3.50 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $64.9M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $232.4M |
| 总资产 | $4.5B | $426.9M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHGRDN
| Q1 26 | — | $64.9M | ||
| Q4 25 | $304.0M | $65.6M | ||
| Q3 25 | $215.0M | $36.5M | ||
| Q2 25 | $207.0M | $18.8M | ||
| Q1 25 | $168.0M | $14.0M | ||
| Q4 24 | $219.0M | — | ||
| Q3 24 | $300.0M | $37.2M | ||
| Q2 24 | $399.0M | — |
总债务ASHGRDN
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $0 | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $34.3M | ||
| Q2 24 | $1.3B | — |
股东权益ASHGRDN
| Q1 26 | — | $232.4M | ||
| Q4 25 | $1.9B | $217.9M | ||
| Q3 25 | $1.9B | $195.5M | ||
| Q2 25 | $1.9B | $179.7M | ||
| Q1 25 | $2.6B | $163.2M | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.9B | $133.9M | ||
| Q2 24 | $3.0B | — |
总资产ASHGRDN
| Q1 26 | — | $426.9M | ||
| Q4 25 | $4.5B | $412.7M | ||
| Q3 25 | $4.6B | $390.0M | ||
| Q2 25 | $4.6B | $356.3M | ||
| Q1 25 | $5.2B | $334.0M | ||
| Q4 24 | $5.2B | — | ||
| Q3 24 | $5.6B | $348.0M | ||
| Q2 24 | $5.7B | — |
负债/权益比ASHGRDN
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | 0.00× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | 0.26× | ||
| Q2 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $6.1M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.45× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHGRDN
| Q1 26 | — | $6.1M | ||
| Q4 25 | $125.0M | $34.6M | ||
| Q3 25 | $40.0M | $28.2M | ||
| Q2 25 | $115.0M | $19.9M | ||
| Q1 25 | $9.0M | $17.6M | ||
| Q4 24 | $-30.0M | — | ||
| Q3 24 | $80.0M | — | ||
| Q2 24 | $127.0M | — |
自由现金流ASHGRDN
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | $24.2M | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $98.0M | — |
自由现金流率ASHGRDN
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | 6.4% | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 18.0% | — |
资本支出强度ASHGRDN
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | 1.1% | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 5.3% | — |
现金转化率ASHGRDN
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.29× | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | 0.29× | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
GRDN
暂无分部数据
